Plesiomonas shigelloides Bacteremia: A Scoping Review of Epidemiology, Clinical Characteristics, Outcomes, and Implications of Antimicrobial Stewardship
Pathogens · 2026
DOI: 10.3390/pathogens15010123 ↗Kurz gefasst
Scoping Review in der Zeitschrift Pathogens, 2026. Verfasst von Nur Izzatul Auni Romli und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Microbiology, Faculty of Medicine, Universiti Malaya, Lembah Pantai, Kuala Lumpur 50603, Malaysia. Hauptthemen laut MEDLINE: Plesiomonas, Bacteremia, Gram-Negative Bacterial Infections, Anti-Bacterial Agents. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Plesiomonas shigelloides, an aquatic Gram-negative bacillus often associated with self-limiting gastroenteritis, has been reported worldwide. However, to date, no reviews have specifically investigated P. shigelloides bacteremia, which is rare and potentially fatal. This scoping review aimed to examine the existing literature to identify the epidemiology, clinical characteristics, antimicrobial susceptibility, and outcomes of P. shigelloides bacteremia. A PRISMA-ScR-guided search of PubMed, Scopus, Web of Science, and Embase identified 22 published cases, all reported as single-patient case reports. Cases were globally distributed, with the majority reported from the Americas and Europe. The median patient age was 46 years. The case fatality rate was 27.3% (n = 6/22). Most patients had identifiable host risk factors, particularly hematological disorders, neonatal status, or immunocompromised status, and environmental exposure such as raw seafood consumption or contact with freshwater. Clinical presentations were heterogeneous, commonly including fever and sepsis or septic shock. Microbiologically, P. shigelloides demonstrated consistent intrinsic resistance to ampicillin while retaining susceptibility to multiple antimicrobial classes. Poor outcomes were more closely associated with host factors and delayed presentation than with antimicrobial resistance. Early diagnosis, targeted therapy, and antimicrobial stewardship are essential for optimizing outcomes in this rare but severe infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Microbiology, Faculty of Medicine, Universiti Malaya, Lembah Pantai, Kuala Lumpur 50603, Malaysia.
- Kementerian Kesihatan Malaysia, National Institutes of Health (NIH), No. 1, Jalan Setia Murni U13/52, Seksyen U13, Bandar Setia Alam, Shah Alam 40170, Malaysia.
ORCID-Profile: Nur Izzatul Auni Romli, Kartini Abdul Jabar
Zitieren
APA
Romli, N. I. A., Mohamed Sukur, S., Vellasamy, K. M., & Abdul Jabar, K. (2026). Plesiomonas shigelloides Bacteremia: A Scoping Review of Epidemiology, Clinical Characteristics, Outcomes, and Implications of Antimicrobial Stewardship. Pathogens. https://doi.org/10.3390/pathogens15010123
Vancouver
Romli NIA, Mohamed Sukur S, Vellasamy KM, Abdul Jabar K. Plesiomonas shigelloides Bacteremia: A Scoping Review of Epidemiology, Clinical Characteristics, Outcomes, and Implications of Antimicrobial Stewardship. Pathogens. 2026. doi:10.3390/pathogens15010123
BibTeX
@article{Romli2026,
author = {Romli, Nur Izzatul Auni and Mohamed Sukur, Salina and Vellasamy, Kumutha Malar and Abdul Jabar, Kartini},
title = {Plesiomonas shigelloides Bacteremia: A Scoping Review of Epidemiology, Clinical Characteristics, Outcomes, and Implications of Antimicrobial Stewardship},
journal = {Pathogens},
year = {2026},
doi = {10.3390/pathogens15010123}
}
EUVIMED